Daclizumab in anaplastic large cell lymphoma.
Grigg
Andrew
A
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000077561:Daclizumab; D018450:Disease Progression; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D017728:Lymphoma, Large-Cell, Anaplastic / Q000175:diagnosis / Q000188:drug therapy*; D012008:Recurrence; D017211:Treatment Failure
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; D000077561:Daclizumab